| Study Period | 2019 - 2032 |
| Market Size in 2024 | USD 2.5 Billion |
| Market Size in 2025 | USD 2.7 Billion |
| Market Size by 2032 | USD 5.5 Billion |
| Projected CAGR | 10.2% |
| Largest Region | North America |
| Fastest Growing Region | APAC |
| Market Structure | Consolidation |
Explore the market potential with our data-driven report
The global PTA balloon catheter market size was USD 2.5 billion in 2024, which is predicted to reach USD 5.5 billion by 2032, growing at a CAGR of 10.2% during 2025–2032.
The market is driven by the increasing prevalence of cardiovascular diseases, growing number of minimally invasive surgical procedures, and rising consumption of tobacco and incidence of obesity.
As of 2024, approximately 30% of the individuals aged 14 and older in Germany are active cigarette smokers, based on findings from the DEBRA study—a nationally representative survey. This marks a significant increase from around 26–27% in 2019–2020 and aligns with the upward trend noted in 2021, when smoking rates exceeded 30%. While WHO-standardized estimates report lower figures of about 21–22%, these are model-based and often underrepresent actual behavior.
The latest data also reveals a troubling decline in attempts to quit, with only 7.7% of the smokers making a serious one in 2024, compared to 30.4% in 2016, and just 19.5% of those using evidence-based cessation methods. This sharp rise in smoking prevalence, combined with low cessation efforts, highlights a growing public health challenge in Germany, potentially increasing the burden of smoking-related illnesses, such as cardiovascular disease.
A person who smokes fewer than five cigarettes a day may also show signs of a CVD. The cells that line the blood vessels become inflamed and swollen because the chemicals in cigarette smoke make the lumen thin and cause various vascular problems.
The demand for PTA balloon catheters is also growing due to the rising number of minimally invasive surgical procedures. This technique is now one of the standards in numerous routine operations. This is mainly because it results in fewer and smaller scars, lesser pain, lower risk of post-operative complications, and faster recoveries; is cost-effective, and has overall better outcomes. Moreover, it has been found that American hospitals could collectively prevent thousands of post-surgical complications and save up to USD 350 million each year by opting for minimally invasive surgeries for routine operations.
In the coming years, companies in the market can leverage the growth opportunities being offered by developing countries. an increasing number of people in emerging economies, including China and India, are becoming subject to stressful lifestyles, insufficient sleep, lack of exercise, and poor diet, all of which increase the prevalence of CVDs. Moreover, developing nations are also reporting a large number of aged people, who are prone to cardiac diseases. All these factors are together raising the demand for cardiac procedures, including angioplasties, thereby offering PTA balloon catheter providers several lucrative opportunities.
The nylon category held the larger market share, of 75%, in 2024. This is primarily because nylon offers high tensile strength and burst resistance, which are critical during angioplasty procedures. Here, balloons are inflated under high pressure to open narrowed or blocked blood vessels. Its semi-compliant nature allows for controlled expansion, giving surgeons the precision they need. Additionally, nylon catheters are relatively easy to manufacture and have been in use for many years, contributing to their widespread adoption across hospitals and clinics worldwide.
The material types analyzed here are:
The peripheral vascular disease category held the larger market share, of 85%, in 2024. The prevalence of this disease in the U.S. is 45 to 50 million. The incidence of the disease increases sharply with age, with more than 20% of the people over 80 years old having it. It majorly results from progressive atherosclerotic disease, which results in a decrease in major organ blood flow and emergence of end-organ ischemia.
The most-common cause is atherosclerosis, which is a buildup of fatty deposits within the blood vessels, which reduces blood flow to that area. Apart from this, other causes are diabetes; a high level of sugar in the blood can damage and weaken the blood vessels, causing them to narrow. Infections, such as syphilis or salmonellosis, can also cause this disease.
Some autoimmune diseases can also cause inflammation of the arteries, which eventually causes peripheral vascular disease. People who are prone to this condition include tobacco users, diabetes mellitus, hypertension, HIV, and high cholesterol patients; a person whose BMI is greater than 30, people who have a medical history of stroke, CVDs, or heart attack or a family history of peripheral vascular disease, stroke, or coronary artery disease; and obese person.
The applications analyzed here are:
The ambulatory surgical centers category will grow at the higher CAGR, of 10.5%, during the forecast period, because they offer a more-convenient and cost-effective setting for minimally invasive procedures. These centers are increasingly being equipped with advanced medical technologies and staffed by skilled healthcare professionals, making them well-suited for performing angioplasty procedures safely outside of traditional hospital settings. Patients often prefer ASCs because they typically provide shorter wait times, faster recovery, and reduced overall costs compared to hospitals. Healthcare systems also support ASCs to reduce the burden on hospitals and improve resource efficiency. As a result, more PTA procedures are being shifted to these outpatient facilities, leading to a significant rise in demand for PTA balloon catheters in this category.
The end users analyzed here are:
The standard and high-pressure category held the larger market share, of 75%, in 2024, because these catheters are widely used in routine angioplasty procedures to treat peripheral artery disease. They are known for their strong inflation capability, durability, and effectiveness in dilating narrowed blood vessels. These catheters are commonly used in both hospitals and ambulatory settings, making them a staple in vascular interventions. Their broad applicability and proven clinical outcomes contribute to their high demand across global healthcare systems.
The product types analyzed here are:
Drive strategic growth with comprehensive market analysis
North America held the largest global PTA balloon catheter market share, around 40%, in 2024. In the U.S., for many years, cardiovascular diseases have been one of the major causes of death. As per the CDC, 0.69 million people in the country died of heart diseases in 2021, with more than one death every minute. Moreover, 1 out of every 3 adults are obese because of high calorie consumption, less physical activity, lack of opportunity and settings for exercise, oversized food portions, genetic factors, stress and emotional factors, and certain diseases, such as thyroid issues, Cushing’s syndrome, and polycystic ovary syndrome. Moreover, the U.S. government spends a significant portion of its gross domestic product (GDP) on healthcare every year.
The APAC market is growing at the highest CAGR, mainly because of the rising prevalence of issues related to the heart and increasing aging population. In India, the most-common heart diseases are cardiomyopathy, coronary artery disease, rheumatic heart disease, valvular heart disease, cerebrovascular disease, heart attack, and heart failure. Factors such as economic development and the rising healthcare expenditure are expected to boost the growth of the market over the forecast period. The growing interest of private companies in investing in this market and the favorable government policies for cardiovascular disease patients are some of the other factors that are projected to boost the market advance over the forecast period.
In addition, health tourism activities are increasing in the country, which drives the market. APAC has also become the center of the global tobacco epidemic, and, unavoidably, it will face a rising burden of tobacco-related health problems in the years to come. Starting at a younger age, a growing proportion of males are smoking.
In India, the quality of healthcare is progressing at a high rate. The country is one of the best medical tourism destinations, offering high-quality treatments at low costs, which is why it is now considered among the top six medical travel destinations in the world. Each year, around 2 million patients visit the country for medical advice and treatment. Hospitals in the country now utilize advanced technologies for the diagnosis and treatment of cardiac ailments. Another prominent factor for the rising arrival of heart patients in the country is that they get an appointment with a well-known cardiologist with relative ease.
Globally, China is the largest manufacturer and consumer of tobacco products. There are more than 300 million smokers in China, accounting for more than 33% of the world's total. Over half the adult men are tobacco smokers in the country, and it accounts for about one in every three cigarettes smoked across the globe. Moreover, there are more than 250 million tobacco users in India, making it the country with the second-highest number of tobacco users, globally, after China.
The market in Europe is also growing at a significant rate. The increasing adoption of minimally invasive surgeries, growing geriatric population, rising number of approved products, and presence of favorable reimbursement policies are expected to boost the market in the region in the coming years.
In Italy, the increasing prevalence of heart diseases and resultant surge in the number of heart surgeries are expected to drive the market. The increasing number of ongoing clinical studies in this country is another factor expected to boost the market. In the country, more than 3 million people were suffering from heart diseases in February 2021. Therefore, the number of heart surgeries continues to increase in Italy, in turn, propelling the demand for balloon catheters for percutaneous transluminal angioplasties.
The regions and countries analyzed in this report are:
The global PTA balloon catheter market is consolidated as a few major players hold a significant share of the market. This consolidation is driven by factors such as the strong brand recognition, extensive distribution networks, and substantial financial resources of these leading companies. Their ability to invest heavily in research and development allows them to introduce innovative products, thereby maintaining competitive advantages and reinforcing their market positions. Furthermore, the economies of scale enjoyed by these dominant companies help streamline operations, reduce costs, and enhance profitability.
Want a report tailored exactly to your business need?
Request CustomizationLeading companies across industries trust us to deliver data-driven insights and innovative solutions for their most critical decisions. From data-driven strategies to actionable insights, we empower the decision-makers who shape industries and define the future. From Fortune 500 companies to innovative startups, we are proud to partner with organisations that drive progress in their industries.
Working with P&S Intelligence and their team was an absolute pleasure – their awareness of timelines and commitment to value greatly contributed to our project's success. Eagerly anticipating future collaborations.
McKinsey & Company
India
Our insights into the minutest levels of the markets, including the latest trends and competitive landscape, give you all the answers you need to take your business to new heights
We take a cautious approach to protecting your personal and confidential information. Trust is the strongest bond that connects us and our clients, and trust we build by complying with all international and domestic data protection and privacy laws
Customize the Report to Align with Your Business Objectives
Request the Free Sample Pages